- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01750203
Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay
December 19, 2012 updated by: Systagenix Wound Management
The objective of this study is to collect wound exudate (fluid) swab samples from Subjects who have wounds that show clinical signs of infection, as well as from Subjects who have wounds that do not show clinical signs of infection.
Swab samples will be collected from acute and chronic wounds of different etiologies and these will be analysed for bacteria types and markers of infection.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
135
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74135
- St. John Wound Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adult subjects (greater than 18 years old), presenting at participating clinical sites with wounds of different etiologies, who are willing to provide informed consent and who meet the inclusion / exclusion criteria, will be prospectively enrolled
Description
Inclusion Criteria:
- Subject has presented to participating study site with a wound(s) suspected to be infected, as determined by the Investigator and/ or study staff - defined as one that through clinical judgment has questionable infection status, and /or shows three or more of the NERDS or STONES signs of infection);
- Subject has presented to participating study site with a wound(s) suspected not to be infected, as determined by the Investigator and/ or study staff - defined as one that does not show three or more of the NERDS or STONES signs of infection.
- Subject is 18 years of age or older.
- Subject agrees to complete all aspects of the study and provides Informed Consent
Exclusion Criteria:
- Subject is less than 18 years of age.
- Target wound contains a malignancy
- Subject has hypersensitivity of the wound or painful wound surface which prevents touching/swabbing of the wound surface.
- Subject is confirmed to be positive for HIV or hepatitis.
- Subject is unable or unwilling to provide informed consent.
- Subjects deemed inappropriate for the study by the site's Principal Investigator.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
No treatment
No cohort as this study is not using a treatment or intervention only swabs are being collected.
|
There is no intervention only swabs are being used to collect wound fluid samples
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The biochemical differences between clinically infected and non infected wounds.
Time Frame: 1 day
|
Wound exudate (fluid) swab samples from different etiologies of wounds will be collected.
Subjects who have wounds that do not show clinical signs of infection, as well as Subjects who have wounds that do show clinical signs of infection will be enrolled.
a maximum of four (4) swab sample from Subjects from whom Informed Consent has been obtained.
The swabs will be subjected to various tests methods that may include, but are not limited to, the following: 1) quantitative bacterial cultures (for aerobic and / or anaerobic bacteria), 2) "for research use only" testing on test formats currently in development by the sponsor (note: this data will not be used to support regulatory filings, such as CE marking or FDA submissions for U.S. market clearance), 3) molecular microbiology, and 4) protease analysis.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tom Serena, MD, SerenaGroup, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
December 7, 2012
First Submitted That Met QC Criteria
December 12, 2012
First Posted (Estimate)
December 17, 2012
Study Record Updates
Last Update Posted (Estimate)
December 20, 2012
Last Update Submitted That Met QC Criteria
December 19, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBIR-001-A
- Systagenix (Other Identifier: Systagenix)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Wounds With Different Etiologies
-
Procter and GambleCompletedPeripheral Sensory Neuropathy of Different EtiologiesMexico
-
National Taiwan University HospitalUnknownHealthy Subjects With Different ConstitutionsTaiwan
-
University Health Network, TorontoUnknownEndothelial Cell Loss With Different Insertion DevicesCanada
-
University Health Network, TorontoUnknownEndothelial Cell Loss With Different Insertion DevicesCanada
-
Cairo UniversityNorhan Abdel Aleem Ali; Hagar hassanein refaee; Ahmed Abdullah Fathi Mohamed...CompletedThree Different Doses of Intrathecal Hyperbaric Prilocaine With FentanylEgypt
-
Al-Azhar UniversityEnrolling by invitationEffect of Platelet Rich Fibrin With Different Tooth MovementsEgypt
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanRecruitingHealthy Participants With Different Skin Types and Different Ages | Diseased Participants With Different Skin Types and Different Ages | Participants Suffered From Diabetes With Different Skin Types and Different AgesTaiwan
-
Postgraduate Institute of Medical Education and...CompletedCompare Central Line Insertion of Subclavian Vein With Two Different Approaches Using Ultrasound
-
University of Sao PauloCompletedTo Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual AcuityBrazil
-
Taipei Medical University WanFang HospitalUnknownAITd Patients With Different PolymorphismsTaiwan
Clinical Trials on Swabs
-
Western Galilee Hospital-NahariyaRecruiting
-
University Hospital, BordeauxCentre National de la Recherche Scientifique, FranceNot yet recruitingVitiligo | Skin MelanomaFrance
-
Systagenix Wound ManagementCompleted
-
Meir Medical CenterCompleted
-
Poitiers University HospitalCompletedRespiratory Tract Viral InfectionFrance
-
Larena SASCEN Biotech; Luxia ScientificCompleted
-
Medical University of ViennaUniversity of ViennaUnknown
-
Loma Linda UniversityRecruitingPreterm Delivery | Bacterial VaginosisUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingRespiratory Syncytial Virus InfectionsFrance
-
Assistance Publique - Hôpitaux de ParisCompletedMyeloproliferative DisordersFrance